Xortx Therapeutics Inc opened trading today at $4.64 and closed at $4.50. Intraday prices ranged from a low of $4.50 to a high of $4.65.

Share prices dipped -2.39% from the previous day's close of $4.61.

Today across North America, the TSX Composite closed -0.95% at 21899.99, the S&P 500 closed -1.46% at 5123.41, the Dow Jones Industrial Average closed -1.24% at 37983.24 and the Nasdaq Composite closed -1.62% at 16175.09.

Xortx Therapeutics Inc has listed on the Toronto Venture Exchange (TSX-V) under the ticker XRTX.

Trading volume was 6,237 on 25 total trades, with an average volume of 2,912 over 5 days.

The TSX-V overall saw 939 price advancers against 4,327 declines and 94 unchanged.

During the prior 52 weeks, XRTX.VN has traded as high as $10.62 (April 20,2023) and low as $2.65 (December 28,2023). Moreover, the shares have shrunken -47.92 percent in the last year, while they have soared 55.17% this year.

Following today's trading, Xortx Therapeutics Inc has a market capitalization of $13.36 million on a float of 2,899 shares outstanding. Its annual EPS is $-3.60.

Xortx Therapeutics Inc is a TSX Biotechnology company headquartered in Calgary, CAN.

Xortx Therapeutics Inc's average recommendation is "Strong Sell" based on 0.00 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..